Ovid Therapeutics Inc.
OVID | NASDAQ
$2.83
+$0.12 (+4.43%)
Sep 22, 2026, 2:16 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -6.79 | -2.52 | -4.35 | -2.42 | 1.80 | -1.66 |
PEG Ratio | 0.19 | 0.05 | 1.12 | 0.02 | -0.01 | 0.21 |
PS Ratio | 16.57 | 116.97 | 579.77 | 87.17 | 1.04 | 10.70 |
PB Ratio | 0.92 | 0.97 | 2.59 | 0.99 | 1.21 | 3.09 |
P/FCF Ratio | -3.14 | -1.18 | -4.95 | -2.31 | 1.83 | -2.60 |
P/OCF Ratio | -3.14 | -1.18 | -4.96 | -2.37 | 1.83 | -2.62 |
OCF/S Ratio | -528.60 | -9.89K | -11.68K | -3.68K | 56.92 | -408.84 |
Debt / Equity Ratio | 0.10 | 0.22 | 0.18 | 0.13 | n/a | n/a |
Quick Ratio | 10.91 | 5.32 | 9.55 | 18.79 | 12.87 | 3.39 |
Current Ratio | 10.91 | 5.32 | 9.55 | 18.79 | 12.87 | 3.39 |
Asset Turnover | 0.05 | 0.01 | 0 | 0.01 | 1.07 | 0.17 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -13.33% | -38.74% | -59.61% | -40.95% | 68.34% | -185.73% |
Return on Assets | -11.54% | -28.68% | -36.34% | -34.89% | 63.14% | -106.73% |
Return on Invested Capital | -29.46% | -74.58% | -44.31% | -37.33% | 68.36% | -151.18% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 95.86% | 100% | 100% | 100% | 100% | 100% |
Net Profit Margin | -240.13% | -4.67K% | -13.35K% | -3.6K% | 58.95% | -642.26% |
Pretax Profit Margin | -240.13% | -4.67K% | -13.35K% | -3.6K% | 59.58% | -642.26% |
Operating Profit Margin | -585.20% | -10.93K% | -15.12K% | -3.7K% | 59.61% | -645.40% |
FCF Margin | -528.60% | -9.9K% | -11.71K% | -3.77K% | 56.83% | -411.93% |
EBITDA Margin | -235.99% | -10.21K% | -14.54K% | -3.6K% | 59.72% | -642.96% |
Add to Watchlist
Select watchlists to add or remove OVID